Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers.
Lu Y, Gao J, Hou Y, Yang H, Wang D, Zhang G, Qin Z, Du P, Wang Z, Wang Y, Chen Q, Sun Z, Li P, Zhang J, Tang J.
Lu Y, et al.
J Immunother Cancer. 2025 Jan 7;13(1):e010127. doi: 10.1136/jitc-2024-010127.
J Immunother Cancer. 2025.
PMID: 39773567
Free article.